Research Abstract

Dr Kabraji is a physician-scientist using single cell approaches to understand how cell cycle states contribute to drug resistance and cancer relapse in cancer. He has developed novel approaches to measuring cell cycle states in tissues from mouse models and human tumors. Current efforts are focused on translational validation and mechanistic understanding of quiescent cancer cell heterogeneity within untreated and treated tumors. As a physician at Dana Farber Cancer Institute, Dr Kabraji specializes in the treatment of patients with breast cancer brain metastases.